Atlas Trials

Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP

Clinical trial NCT03632772 · UNKNOWN

Trial details

NCT number
NCT03632772
Sponsor
Buddhist Tzu Chi General Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Overactive Bladder Syndrome
Start date
2018-08-01
Primary completion
2019-07-31
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.